NMTC

Steve Mertens

Known title: Chief Technology OfficerCIK: 0001772652

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 5, 2026

NeuroOne Reports Strong Q4 Sales, New $4.5M Order. NeuroOne Medical Technologies said its Q4 sales were about $3.8 million, up 38% from last year. The company also added a $4.5 million purchase order in September and expects FY26 sales of roughly $10.5 million, a 15.6% increase year‑over‑year. These results come as the share price sits near its 12‑touch support level of $1.63 and an RSI of 45.8.

this person other insiders at NMTC

Transaction History

NMTC▼ Sell$704
NMTC▼ Sell$5K
NMTC▼ Sell$687
NMTC▼ Sell$805
NMTC▼ Sell$614
NMTC▼ Sell$770
NMTC▼ Sell$9K
NMTC▼ Sell$290
NMTC▼ Sell$957
NMTC▼ Sell$157
NMTC▼ Sell$244
NMTC▼ Sell$1K
NMTC▼ Sell$201
NMTC▼ Sell$189
NMTC▼ Sell$926
NMTC▼ Sell$234
NMTC▼ Sell$285
NMTC▼ Sell$8K
NMTC▼ Sell$302
NMTC▼ Sell$305
NMTC▲ Buy$0
NMTC▼ Sell$315
NMTC▼ Sell$398
NMTC▼ Sell$365
NMTC▼ Sell$406
NMTC▼ Sell$227
NMTC▼ Sell$224
NMTC▼ Sell$214
NMTC▼ Sell$257
NMTC▼ Sell$302
NMTC▼ Sell$305
NMTC▼ Sell$388
NMTC▲ Buy$0
NMTC▼ Sell$406
NMTC▼ Sell$9K
NMTC▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.